Works matching AU Fujita, Yuka


Results: 35
    1

    Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601.

    Published in:
    Oncology, 2011, v. 81, n. 2, p. 84, doi. 10.1159/000331681
    By:
    • Akie, Kenji;
    • Oizumi, Satoshi;
    • Ogura, Shigeaki;
    • Shinagawa, Naofumi;
    • Kikuchi, Eiki;
    • Fukumoto, Shinichi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Kojima, Tetsuya;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Ohsaki, Yoshinobu;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    2
    3

    Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae168
    By:
    • Ohhara, Yoshihito;
    • Kojima, Tetsuya;
    • Honjo, Osamu;
    • Yamada, Noriyuki;
    • Sato, Toshitaka;
    • Takahashi, Hirofumi;
    • Takamura, Kei;
    • Takashina, Taichi;
    • Sukoh, Noriaki;
    • Tanaka, Hisashi;
    • Kawai, Yasutaka;
    • Fujita, Yuka;
    • Yokoo, Keiki;
    • Hommura, Fumihiro;
    • Harada, Toshiyuki;
    • Honda, Ryoichi;
    • Amano, Toraji;
    • Dosaka-Akita, Hirotoshi;
    • Oizumi, Satoshi;
    • Kinoshita, Ichiro
    Publication type:
    Article
    4
    5

    Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 515, doi. 10.1007/s10147-020-01828-1
    By:
    • Kawashima, Yosuke;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Nakagawa, Taku;
    • Watanabe, Kana;
    • Morikawa, Naoto;
    • Takamura, Kei;
    • Kanazawa, Kenya;
    • Kuda, Tomoya;
    • Usui, Kazuhiro;
    • Sekine, Akimasa;
    • Inoue, Akira;
    • Sugawara, Shunichi
    Publication type:
    Article
    6
    7
    8
    9
    10

    Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.

    Published in:
    Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00972
    By:
    • Harada, Toshiyuki;
    • Amano, Toraji;
    • Ikari, Tomoo;
    • Takamura, Kei;
    • Ogi, Takahiro;
    • Fujikane, Toshiaki;
    • Fujita, Yuka;
    • Taima, Kageaki;
    • Tanaka, Hisashi;
    • Sasaki, Takaaki;
    • Okumura, Shunsuke;
    • Sugawara, Shunichi;
    • Yokouchi, Hiroshi;
    • Yamada, Noriyuki;
    • Morikawa, Naoto;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    11

    Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
    By:
    • Shimokawa, Mototsugu;
    • Kanazu, Masaki;
    • Saito, Ryusei;
    • Mori, Masahide;
    • Tamura, Atsuhisa;
    • Okano, Yoshio;
    • Fujita, Yuka;
    • Endo, Takeo;
    • Motegi, Mitsuru;
    • Takata, Shohei;
    • Kita, Toshiyuki;
    • Sukoh, Noriaki;
    • Mizuki, Fumitaka;
    • Takenoyama, Mitsuhiro;
    • Atagi, Shinji
    Publication type:
    Article
    12

    Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 14, p. 2113, doi. 10.1111/1759-7714.14048
    By:
    • Hisashi Tanaka;
    • Yukihiro Hasegawa;
    • Yuka Fujita;
    • Atsushi Nakamura;
    • Eiki Kikuchi;
    • Yasutaka Kawai;
    • Toshiyuki Harada;
    • Naomi Watanabe;
    • Hiroshi Yokouchi;
    • Kazuhiro Usui;
    • Ryota Saito;
    • Hiroshi Watanabe;
    • Tomomi Masuda;
    • Tatsuro Fukuhara;
    • Keita Kudo;
    • Ryoichi Honda;
    • Satoshi Oizimi;
    • Makoto Maemondo;
    • Akira Inoue;
    • Naoto Morikawa
    Publication type:
    Article
    13
    14
    15
    16
    17

    A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).

    Published in:
    2020
    By:
    • Fukumoto, Shin-ichi;
    • Oizumi, Satoshi;
    • Harada, Masao;
    • Sukoh, Noriaki;
    • Nakano, Kosuke;
    • Fuke, Satoshi;
    • Sakakibara-Konishi, Jun;
    • Takamura, Kei;
    • Ito, Kenichiro;
    • Fujita, Yuka;
    • Nishigaki, Yutaka;
    • Harada, Toshiyuki;
    • Akie, Kenji;
    • Kinoshita, Ichiro;
    • Amano, Toraji;
    • Isobe, Hiroshi;
    • Dosaka-Akita, Hirotoshi;
    • Nishimura, Masaharu;
    • Hokkaido Lung Cancer Clinical Study Group
    Publication type:
    journal article
    18

    A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002).

    Published in:
    2017
    By:
    • Ikezawa, Yasuyuki;
    • Asahina, Hajime;
    • Oizumi, Satoshi;
    • Watanabe, Masahiro;
    • Takamura, Kei;
    • Kawai, Yasutaka;
    • Yamada, Noriyuki;
    • Harada, Toshiyuki;
    • Kinoshita, Ichiro;
    • Fujita, Yuka;
    • Miyauchi, Eisaku;
    • Ogi, Takahiro;
    • Amano, Toraji;
    • Furuta, Megumi;
    • Sakakibara-Konishi, Jun;
    • Nishihara, Hiroshi;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu;
    • Hokkaido Lung Cancer Clinical Study Group
    Publication type:
    journal article
    19

    Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1149, doi. 10.1007/s00280-014-2589-3
    By:
    • Kanazawa, Kenya;
    • Yokouchi, Hiroshi;
    • Wang, Xintao;
    • Ishida, Takashi;
    • Fujita, Yuka;
    • Fujiuchi, Satoru;
    • Harada, Toshiyuki;
    • Harada, Masao;
    • Takamura, Kei;
    • Oizumi, Satoshi;
    • Kinoshita, Ichiro;
    • Katsuura, Yutaka;
    • Honjo, Osamu;
    • Kojima, Tetsuya;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Munakata, Mitsuru;
    • Nishimura, Masaharu
    Publication type:
    Article
    20
    21

    First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02561-z
    By:
    • Yamamoto, Gaku;
    • Asahina, Hajime;
    • Honjo, Osamu;
    • Sumi, Toshiyuki;
    • Nakamura, Atsushi;
    • Ito, Kenichiro;
    • Kikuchi, Hajime;
    • Hommura, Fumihiro;
    • Honda, Ryoichi;
    • Yokoo, Keiki;
    • Fujita, Yuka;
    • Oizumi, Satoshi;
    • Morita, Ryo;
    • Ikezawa, Yasuyuki;
    • Tanaka, Hisashi;
    • Kimura, Nozomu;
    • Sasaki, Takaaki;
    • Sukoh, Noriaki;
    • Takashina, Taichi;
    • Harada, Toshiyuki
    Publication type:
    Article
    22
    23
    24
    25

    Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 6, p. 475, doi. 10.1634/theoncologist.2019-0746
    By:
    • Tsuchiya‐Kawano, Yuko;
    • Sasaki, Tomonari;
    • Yamaguchi, Hiroyuki;
    • Hirano, Katsuya;
    • Horiike, Atsushi;
    • Satouchi, Miyako;
    • Hosokawa, Shinobu;
    • Morinaga, Ryotaro;
    • Komiya, Kazutoshi;
    • Inoue, Koji;
    • Fujita, Yuka;
    • Toyozawa, Ryo;
    • Kimura, Tomoki;
    • Takahashi, Kosuke;
    • Nishikawa, Kazuo;
    • Kishimoto, Junji;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    Article
    26

    Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.

    Published in:
    Oncologist, 2020, v. 25, n. 4, p. 306, doi. 10.1634/theoncologist.2019-0728
    By:
    • Iwama, Eiji;
    • Goto, Yasushi;
    • Murakami, Haruyasu;
    • Tsumura, Shinsuke;
    • Sakashita, Hiroyuki;
    • Mori, Yoshiaki;
    • Nakagaki, Noriaki;
    • Fujita, Yuka;
    • Seike, Masahiro;
    • Bessho, Akihiro;
    • Ono, Manabu;
    • Nishitsuji, Masaru;
    • Akamatsu, Hiroaki;
    • Morinaga, Ryotaro;
    • Akagi, Takanori;
    • Shimose, Takayuki;
    • Tokunaga, Shoji;
    • Yamamoto, Nobuyuki;
    • Nakanishi, Yoichi;
    • Sugio, Kenji
    Publication type:
    Article
    27

    Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).

    Published in:
    Oncologist, 2019, v. 24, n. 11, p. e1172, doi. 10.1634/theoncologist.2018-0676
    By:
    • Furuta, Megumi;
    • Sakakibara‐Konishi, Jun;
    • Kikuchi, Hajime;
    • Yokouchi, Hiroshi;
    • Nishihara, Hiroshi;
    • Minemura, Hiroyuki;
    • Harada, Masao;
    • Yamazaki, Shigeo;
    • Akie, Kenji;
    • Fujita, Yuka;
    • Takamura, Kei;
    • Kojima, Tetsuya;
    • Harada, Toshiyuki;
    • Minami, Yoshinori;
    • Watanabe, Naomi;
    • Oizumi, Satoshi;
    • Suzuki, Hiroyuki;
    • Nishimura, Masaharu;
    • Dosaka‐Akita, Hirotoshi;
    • Isobe, Hiroshi
    Publication type:
    Article
    28
    29

    A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 439, doi. 10.1634/theoncologist.2012-0308
    By:
    • Harada, Toshiyuki;
    • Oizumi, Satoshi;
    • Ito, Kenichiro;
    • Takamura, Kei;
    • Kikuchi, Eiki;
    • Kuda, Tomoya;
    • Sugawara, Shunichi;
    • Suzuki, Aya;
    • Maemondo, Makoto;
    • Fujita, Yuka;
    • Kinoshita, Ichiro;
    • Inoue, Akira;
    • Hommura, Fumihiro;
    • Katsuura, Yutaka;
    • Dosaka‐Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    30
    31
    32
    33
    34

    Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 107, doi. 10.1007/s10549-021-06179-7
    By:
    • Tokuda, Yukiko;
    • Yanagawa, Masahiro;
    • Fujita, Yuka;
    • Honma, Keiichiro;
    • Tanei, Tomonori;
    • Shimoda, Masafumi;
    • Miyake, Tomohiro;
    • Naoi, Yasuto;
    • Kim, Seung Jin;
    • Shimazu, Kenzo;
    • Hamada, Seiki;
    • Tomiyama, Noriyuki
    Publication type:
    Article
    35

    Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis.

    Published in:
    Allergy, 2023, v. 78, n. 11, p. 2933, doi. 10.1111/all.15820
    By:
    • Okada, Naoki;
    • Yamamoto, Yoshiro;
    • Oguma, Tsuyoshi;
    • Tanaka, Jun;
    • Tomomatsu, Katsuyoshi;
    • Shiraishi, Yoshiki;
    • Matsuse, Hiroto;
    • Shimoda, Terufumi;
    • Kimura, Hirokazu;
    • Watai, Kentaro;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Obase, Yasushi;
    • Suzukawa, Maho;
    • Suzuki, Junko;
    • Takayanagi, Noboru;
    • Ishiguro, Takashi;
    • Masaki, Katsunori;
    • Fukunaga, Koichi;
    • Asano, Koichiro
    Publication type:
    Article